Jazz Pharmaceuticals has been a great long-term investment since it went public -- but will generic competitors ruin its business?
Max Macaluso, The Motley Fool, The Motley Fool
Thu, 08/23/2012 - 7:24am
Jazz Pharmaceuticals has been a great long-term investment since it went public -- but will generic competitors ruin its business?